首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 62 毫秒
1.
输精管结扎术后痛性结节的病理、细菌和免疫学研究   总被引:6,自引:2,他引:6  
李顺强  徐冰 《生殖与避孕》1994,14(2):118-121
本文报道35例输精管结扎术后痛性结节的研究结果,表明绝大多数痛性结节的病理基础为精子漏出所致精子肉芽肿。它的发生、组织病理学类型、结节大小以及病程长短与抗体的发生率和滴度高低之间没有发现因果关系。细菌感染不是痛性结节产生的原因。  相似文献   

2.
再次输精管结扎术的临床体会杜胜平(四川省邻水县计划生育宣传技术指导站,邻水县,635300)输精管结扎术是一种安全有效、经济简便的男性绝育措施之一,很受广大育龄夫妇欢迎,但由于多种因素也可导致手术失败。据有关文献报道其失败率为0~2.2%,部分因未能...  相似文献   

3.
133例输精管结扎术后并发症检查鉴定结果分析孙中华(四川省武胜县计划生育宣传技术指导站,武胜,638450)输精管结扎术目前虽是一种安全可靠、简便易行、群众较乐意接受的男性绝育方法。但术后并发症的发生还占有一定比例。本文在全县64013例男扎术中经检...  相似文献   

4.
<正> 输精管阻断后,近睾端输精管、附睾管内精子及睾液郁积,管内静水压升商,管腔明显扩张,以致可发生管腔内郁积、破裂或漏出,精子外溢造成附睾无菌性炎症,甚至在临床上出现症状,称为附睾郁积症。附睾郁积的因素,尚未见系统研究报告,为此,我们  相似文献   

5.
48例正常育龄男子和24例要求作输精管吻合术者,用免疫珠结合试验(IBT)和精子-宫颈粘液接触试验(SCMC)分别检测其近睾端输精管液中的精子(非射出的精子)表面抗精子抗体的情况。结果显示:正常育龄男子非射出的精子上没有抗体存在;而输精管结扎术后非射出的精子上有抗精子抗体存在(IgG:79.4%,IgA:38.2%,SCMC:35.5%)。这些抗体在输精管结扎术后不到1年就可发现,并保持到结扎术后3年以上。吻合术后1~3个月内,其精液中射出的精子上仍发现抗体存在。结果还提示:输精管结扎术后,不能以非射出的精子上抗体的水平去预测吻合术后射出的精子上抗体的水平;吻合术前血清抗体水平与非射出的精子上抗体水平并不一致。  相似文献   

6.
输精管组织学观察及输精管结扎术后并发症的探讨   总被引:1,自引:0,他引:1  
<正>本文对106例成年人进行输精管结扎,术后对211根忙精管组织进行了组织学显微观察并分类.术后对受术者进行远期随访,结合输精管组织学观察,对输精管结扎术后并发症进行了分析与讨论.  相似文献   

7.
<正> 编辑同志:近年来,我们开展了许多输精管结扎手术,术后部分人出现了一些并发症,其中以痛性结节与附睾淤积症为多见。我们很想了解为什么会产生这类并发症,更想知道如何预防并治疗这些并发症。这对我们基层推广男性绝育术是十分重要的,希望得到时及的指导。此致敬礼陈金光张枫1982年3月陈金光、张枫同志:编辑部转来了你们的信,信中所要了解的几个问题,也是男性计划生育技术工作者经常提出的一些问题。我们只能肤浅地谈一些体会,作为同行之间的一  相似文献   

8.
两种输精管阻断术后血清抗精子抗体检测   总被引:9,自引:1,他引:8  
<正> 输精管结扎术(简称结扎术)后男性血清中产生抗精子抗体(AsAb)已被确认。Hellema 等报道在一组输精管吻合术后男性中,13例精液恢复正常且计数>20×10~6/ml,但仅3例复育(复育率占23%),不育原因与存在 AsAb 有关。可复性输精管注射栓堵术(简称栓堵术)术后血清中是否存在 AsAb 尚未见报道。我们用 TAT 和 ELISA 两种方法对62例男性作了栓堵术前、后血清中 AsAb 的测定,对62例结扎术后男性进行了血清 AsAb 的测定。  相似文献   

9.
应用显微外科输精管吻合术21例的体会   总被引:1,自引:0,他引:1  
应用显微外科输精管吻合术21例的体会程守先,舒畅,陶智潞(华北煤炭医学院附属医院显微整形外科,唐山,063000)马焕明(唐山市计划生育协作组,唐山,063000)应用显微外科技术进行输精管复通术是落实计划生育政策、解除结扎术后顾之忧的一项重要措施。...  相似文献   

10.
输精管结扎术后附睾瘀积—发生机制及其防治方法的研究   总被引:10,自引:1,他引:10  
木文对输精管结扎后的“附睾瘀积”进行了系统研究。选用金黄地鼠为实验动物,结扎组84只,对照组76只。采用微穿刺、微量分析方法证实扎管后附睾功能受损。组织学检查示附睾管扩张,间质充血,有大量慢性炎细胞浸润。临床收集49例病人,39例微波治疗,10例手术,效果优良。采用B超、C超、MRI观察瘀积附睾,发现附睾瘀积多位于附睾尾部。人类标本的光镜及电镜检查证实,附睾瘀积的病理实质是附睾对外渗精子的一种无菌性炎症反应。本文根据研究资料,阐明了附睾瘀积的发生机制,提出了防治方法,并定名为“附睾瘀积综合征”。  相似文献   

11.
B Luo 《中华妇产科杂志》1990,25(3):156-8, 188-9
Fifty-four cases of vulval carcinoma are reported. The over all 5-year survival rate was 87%. In 32 cases treated by surgery alone and in 15 cases who had combination therapies, the 5-year survival rate was 84% and 80% respectively. The extent of operation was discussed. Continued adjuvant therapies should be given in patients at high risk of recurrence.  相似文献   

12.
13.
14.
Treatment of painful heels using extracorporeal shock wave.   总被引:2,自引:0,他引:2  
BACKGROUND AND PURPOSE: Shock wave therapy has been shown to improve many tendinopathies at the tendon-bone junction. The purpose of this study was to investigate the safety and effectiveness of extracorporeal shock wave therapy for the treatment of painful heels. METHODS: Sixty-six patients, including 45 women and 21 men with an average age of 47.70 years (range, 19-75 years), were included in the study. Each patient received 1,000 impulses of shock waves at a 14-kV generator voltage at the affected site under local anesthesia. Twelve patients received a second treatment, and two patients received a third treatment. RESULTS: Of 58 patients with 6 weeks' follow-up, five (9%) were complaint-free, 21 (37%) were significantly better, 27 (47%) were slightly better, and five (9%) were unchanged. Of 41 patients with 12 weeks' follow-up, 11 (27%) were complaint-free, 22 (54%) were significantly better, seven (17%) were slightly better, and one (2%) was unchanged. The results at 12 weeks were much better than those at 6 weeks. The effect of shock waves on painful heels continued between 6 and 12 weeks. Twelve patients who did not respond favorably to the first treatment showed significantly better results after a second treatment. Two patients who had a third treatment also achieved satisfactory results. There were no device-related problems or systemic or local complications. CONCLUSIONS: Extracorporeal shock wave therapy is a new modality that is safe and effective in the treatment of painful heel spurs.  相似文献   

15.
16.
目的探讨腹腔镜手术治疗肠道子宫内膜异位症(bowel endometriosis,BE)的安全性和有效性。方法回顾性分析2008年6月至2012年5月中山大学附属第一医院妇产科行腹腔镜手术治疗并经病理证实的54例BE患者的临床资料。手术治疗的有效性通过患者的疼痛视觉模拟评分(visual analog scale,VAS)和症状改善的主观感觉(完全缓解、显著缓解、无缓解、加重)进行评价,并观察术后并发症及术后妊娠情况。结果 54例BE患者中15例患者行肠道表面病灶切除术,8例患者行病灶碟形切除术,31例进行腹腔镜节段性肠管切除及吻合术。术后患者各种疼痛症状的VAS评分显著下降(P<0.05)。术后并发症13例,发生率24.1%(13/54),包括直肠阴道瘘2例、尿潴留10例、盆腔脓肿1例。在术后随访超过6个月恢复正常月经的14例不孕且有生育要求的患者中,7例患者妊娠,术后妊娠率50.0%(7/14),其中6例自然受孕(2例足月经阴道分娩、1例足月剖宫产、1例现孕30周、1例孕20周因胎膜早破难免流产、1例孕8周因胚胎停育行清宫术),1例因双侧输卵管阻塞行体外受精-胚胎移植(IVF-ET)术,于孕足月剖宫产。结论腹腔镜手术能有效缓解BE患者的相关疼痛症状,改善术后妊娠情况,是治疗BE的首选手术方式。  相似文献   

17.
妇科腹腔镜手术并发症54例临床分析   总被引:10,自引:0,他引:10  
目的探讨妇科腹腔镜手术并发症发生的相关因素及其防治方法。方法对中南大学湘雅二医院妇科2003年6月至2008年6月妇科腹腔镜手术患者54例并发症的临床资料及相关因素进行回顾性分析。结果4832例妇科腹腔镜手术发生并发症54例(1.12%)。其中腹腔镜全子宫切除术并发症13例,发生率为4.22%(13/308),子宫肌瘤剔除术并发症9例,发生率为1.60%(9/563),附件手术并发症22例,发生率为0.76%(22/2885),其他手术并发症10例,发生率为0.93%(10/1076)。并发症种类主要为血管和周围组织器官损伤、皮下出血、气肿和术中出血等。结论正确掌握手术适应证和合适的开腹时机,可减少腹腔镜手术并发症的发生。  相似文献   

18.
We present a case of mid pregnancy loss with retained intrauterine contraceptive device associated with fetal Candida infection. Review of English literature identified 53 additional cases of fetal candidal infection, with 17 associated with an IUCD in situ. The presence of an IUCD was associated with delivery at a statistically significant earlier gestational age when compared to cases not associated with an IUCD (23.3 +/- 4.9 vs 31.6 +/- 7.0, p < 0.001). Seventy-seven percent of fetal candidal infections associated with an IUCD were systemic (heart, brain, liver, gastrointestinal, lung) compared to 33% of cases not associated with an IUCD. In contrast to bacterial intraamniotic infections there was a low incidence of maternal febrile morbidity. An hypothesis as to the pathogenesis of Candidal infections in the presence and absence of an IUCD is offered as well as a paradigm for the management of the gravid patient with an IUCD in situ.  相似文献   

19.
20.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号